Effect of a conventional energy-restricted modified diet with or without meal replacement on weight loss and cardiometabolic risk profile in overweight women

[1] Bray GA(2004)Medical consequences of obesity J Clin Endocrinol Metab 89 2583-2589

[2] Després JP(2008)Abdominal obesity and the metabolic syndrome: contribution to global cardio-metabolic risk Arterioscler Thromb Vasc Biol 28 1039-1049

[3] Lemieux I(2002)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report Circulation 106 3143-3421

[4] Bergeron J(2003)Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration Am J Clin Nutr 78 928-934

[5] Pibarot P(2008)Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program Am J Clin Nutr 87 1212-1218

[6] Mathieu P(2008)Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels Am J Clin Nutr 88 1263-1271

[7] Larose E(2010)Waist circumference and all-cause mortality in a large US cohort Arch Intern Med 170 1293-1301

[8] Rodés-Cabau J(2003)Association of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study Am J Clin Nutr 77 1192-1197

[9] Bertrand OF(2005)Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity Diabet Med 22 266-272

[10] Poirier P(2008)Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects Endocr J 55 811-818

[1] Bray GA(2004)Medical consequences of obesity J Clin Endocrinol Metab 89 2583-2589

[2] Després JP(2008)Abdominal obesity and the metabolic syndrome: contribution to global cardio-metabolic risk Arterioscler Thromb Vasc Biol 28 1039-1049

[3] Lemieux I(2002)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report Circulation 106 3143-3421

[4] Bergeron J(2003)Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration Am J Clin Nutr 78 928-934

[5] Pibarot P(2008)Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program Am J Clin Nutr 87 1212-1218

[6] Mathieu P(2008)Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels Am J Clin Nutr 88 1263-1271

[7] Larose E(2010)Waist circumference and all-cause mortality in a large US cohort Arch Intern Med 170 1293-1301

[8] Rodés-Cabau J(2003)Association of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study Am J Clin Nutr 77 1192-1197

[9] Bertrand OF(2005)Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity Diabet Med 22 266-272

[10] Poirier P(2008)Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects Endocr J 55 811-818